Dolby Laboratories stock carries a 48.6 percent target gap
Published on 10/04/2026 at 15:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSDolby Laboratories (ISIN US25659T1079) stock was last at USD 58.89 on the NYSE on October 2, 2026, at 4:00 p.m. ET, down 0.29 percent from the prior close. The share price had reached USD 59.66 during the session as MarketBeat reported on October 2, 2026, when the stock moved above its 200-day average of USD 57.64.
Quarterly revenue fell 3.3 percent
Dolby's fiscal third-quarter 2026 results show a split picture. According to AssetNews4U on July 30, 2026, total revenue was USD 305.0 million, compared with USD 315.5 million in fiscal Q3 2025. The same release reported GAAP net income of USD 29.0 million, down from USD 46.0 million, while GAAP diluted earnings per share declined to USD 0.30 from USD 0.48.
Adjusted results were higher than the GAAP figures but also weakened year over year. Adjusted diluted earnings per share came in at USD 0.69, compared with USD 0.78 in the prior-year quarter, while Dolby guided fiscal Q4 2026 revenue to USD 362 million to USD 392 million and adjusted diluted earnings per share to USD 1.13 to USD 1.28, according to AssetNews4U.
Analyst target remains above the stock
The valuation gap is the clearest market checkpoint. MarketBeat reported a Moderate Buy consensus from three analysts, with an average target of USD 87.50 and individual targets from USD 85.00 to USD 90.00. At USD 58.89, the average target lies 48.6 percent above the stock price.
The analyst picture includes both positive and cautious signals. MarketBeat reported that Rosenblatt Securities reaffirmed a Buy rating with an USD 85.00 target on August 28, 2026, while Weiss Ratings raised its rating from Sell to Hold on September 9, 2026. Those views frame Dolby's next challenge as converting platform expansion into revenue growth while the latest quarter shows lower sales and profit.
Stock keeps a wide yearly range
DLB's October 2, 2026 range was USD 48.26 to USD 72.96, placing the last price USD 14.07 below the yearly high and USD 10.63 above the yearly low. Trading volume reached 649,744 shares, while market capitalization stood at USD 5.6 billion. Dolby's licensing portfolio spans Dolby Atmos, Dolby Vision, Dolby Cinema and Dolby OptiView, linking its investment case to adoption across entertainment devices and services.
Dolby Laboratories stock was last at USD 58.89 on the NYSE on October 2, 2026, at 4:00 p.m. ET. The next key financial comparison is between the guided fiscal Q4 revenue range of USD 362 million to USD 392 million and the USD 305.0 million recorded in fiscal Q3.
Dolby Laboratories stock at a glance
- Company: Dolby Laboratories, Inc.
- ISIN: US25659T1079
- Ticker: DLB
- Trading venue: NYSE
- Price (as of October 2, 2026, 4:00 p.m. ET): USD 58.89
- Market capitalization: USD 5.6 billion (as of October 2, 2026)
- 52-week range: USD 48.26-72.96 (as of October 2, 2026)
- Sector / Industry: Technology / Software - Application
